Clinical and radiologic analysis of on-demand use of etanercept for disease flares in patients with rheumatoid arthritis for 2 years: The RESUME study: A case-control study

about

Clinical and radiologic analysis of on-demand use of etanercept for disease flares in patients with rheumatoid arthritis for 2 years: The RESUME study: A case-control study

Item

http://www.wikidata.org/entity/Q58703890

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Clinical and radiologic analys ...... ME study: A case-control study

@en

Clinical and radiologic analys ...... ME study: A case-control study

@nl

type

Item

label

Clinical and radiologic analys ...... ME study: A case-control study

@en

Clinical and radiologic analys ...... ME study: A case-control study

@nl

prefLabel

Clinical and radiologic analys ...... ME study: A case-control study

@en

Clinical and radiologic analys ...... ME study: A case-control study

@nl

P1476

Clinical and radiologic analys ...... ME study: A case-control study

@en

P2093

Akira Sakawa

http://www.w3.org/2001/XMLSchema#string

Hiroaki Nakamura

http://www.w3.org/2001/XMLSchema#string

Kenji Mamoto

http://www.w3.org/2001/XMLSchema#string

Kentaro Inui

http://www.w3.org/2001/XMLSchema#string

Kenzo Fukushima

http://www.w3.org/2001/XMLSchema#string

Masahiro Tada

http://www.w3.org/2001/XMLSchema#string

Tadashi Okano

http://www.w3.org/2001/XMLSchema#string

Tatsuya Koike

http://www.w3.org/2001/XMLSchema#string

Yuko Sugioka

http://www.w3.org/2001/XMLSchema#string

P2860

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study.

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab.

Early medication use in new-onset rheumatoid arthritis may delay joint replacement: results of a large population-based study.

Treatment of rheumatoid arthritis by molecular-targeted agents: efficacy and limitations.

Golimumab and certolizumab: the two new anti-tumor necrosis factor kids on the block.

P304

e12462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000012462

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30235736

http://www.w3.org/2001/XMLSchema#string

P932

6160256

http://www.w3.org/2001/XMLSchema#string